Anlon Healthcare submitted the voting results and the consolidated scrutinizer's report for its 13th Annual General Meeting to the stock exchanges.

The meeting was held on September 5, 2026, through video conferencing or other audio-visual means. The company uploaded the details on its website as well.

Meeting Details

The annual general meeting commenced at 11:10 am and concluded at 11:50 am. Punitkumar Rasadia, the Managing Director, signed the submission letter addressed to the Listing Departments of BSE Limited and the National Stock Exchange of India Ltd.

The submission was made pursuant to Section 108 of the Companies Act, 2013, read with Rule 20 of the Companies (Management and Administration) Rules, 2014.

Anlon Healthcare issued a corrigendum to its Annual General Meeting (AGM) notice on August 25, 2026, addressing observations from the Bombay Stock Exchange and National Stock Exchange regarding its proposed preferential share issue.

The company plans to hold its 13th AGM on September 5, 2026, to seek shareholder approval for the issuance and allotment of equity shares on a preferential basis. The corrigendum revises specific clauses in the notice and explanatory statement to align with regulatory requirements raised by the exchanges on August 18 and August 19, 2026.

Issue Details and Pricing

The preferential issue involves two components: an acquisition of shares from Anlon Orthoplastics Private Limited (AOPL) and a buyback-linked preferential issue (BLPL). The total value of the AOPL component is ₹1,165,179,600, while the BLPL component totals ₹367,840,000.

Shares are being allotted at a price of ₹17.85 per equity share. This pricing is based on the volume-weighted average price on the NSE during the 90 trading days preceding the relevant date, which was determined to be ₹17.78. An independent registered valuer, CA Gaurang Agarwal, confirmed this fair value in a report dated August 6, 2026.

Allotment Structure

The AOPL component involves the allotment of 6,52,76,283 shares to 159 proposed allottees. The largest single allottee in this segment is Punitkumar Rameshbhai Rasadia, who is proposed to receive 1,75,23,043 shares valued at ₹312,786,300.

The BLPL component includes the allotment of 2,06,07,334 shares to 171 proposed allottees. Sanjukumar Rajeshbhai Savani is the largest recipient in this category, with 34,82,353 shares valued at ₹62,160,000.

Promoter Subscription

Only two promoters have indicated an intention to subscribe to the offer:

• Punitkumar Rameshbhai Rasadia (Promoter and Chairman & Managing Director): 1,84,19,402 shares
• Meet Atulkumar Vachhani (Promoter and Whole Time Director): 93,51,099 shares

Shareholding Pattern Impact

Post-issue, the promoter group's shareholding is expected to decrease from 52.68% to 49.85%. Conversely, public shareholding will rise from 47.32% to 50.15%, ensuring compliance with minimum public holding norms. The total number of equity shares will increase from 53,15,15,000 to 61,73,98,617.